PainReform Ltd. Profile
Industry
Drug Manufacturers - Specialty & GenericSector
HealthcareNumber of Employees
7PainReform Ltd.'s Business Model
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
About PainReform Ltd.
Website: https://www.painreform.com
CEO (Chief Executive Officer): Mr. Ilan Hadar M.B.A.
IPO date: 2020-09-01
Contact
Country: IL
Address: 65 Yigal Alon Street
City: Tel Aviv
State: None
Phone: 972 3 717 7050
Zip Code: 6745442
Other
CIK: 0001801834
ISIN: IL0011651580
CUSIP: M77798102
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
